التداخل بين سيميتيدين وسوفوسبوفير وفيلباتاسفير

Clinical Effect/Recommendation Acid Reducing Agents: ↓ velpatasvir Velpatasvir solubility decreases as pH increases.

H 2 -receptor antagonists may be administered simultaneously with or staggered from VOSEVI at a dose that does not exceed doses comparable with famotidine 40 mg twice daily.

H 2 -receptor antagonists (e.g., famotidine) These interactions have been studied in healthy adults.